Should The U.S. Risk Its AI Edge By Letting Nvidia Sell Chips To China?

Should the U.S. allow Nvidia to sell advanced AI chips to China? A clear-eyed look at export controls, national security, innovation and America’s long-term AI leadership.

Chinese Auto Sales In Europe Could Peak At 15% – Report

Sales of Chinese autos in Europe will peak at a market share of between 12 and 15% between 2030 and 2035, helped by building an increasing number of local factories.

Why A Fintech Unicorn Is Donating Millions To Start A Credit Union

Aven, a startup valued at $2 billion that offers a home equity line of credit (HELOC) through a credit card, says credit unions are a proven way to lower consumers’ borrowing costs.

Ferrari Share Slide Slows As Investors Await Financial News

Ferrari shareholders’ worries have driven the stock price down. Will normal service be resumed, and the shares regain their status as a truly luxury investment?

Battered European Auto Investors Can Expect A More Stable 2026

European auto investors can expect some estability in 2026, after suffering in 2025 as profits plummeted, pressured by weak markets, tariff turmoil, and EV mandates.

The Future Of Venture Capital: Strategies That Win

What is noise and what drives real performance in innovation investing? Only four strategies consistently explain venture outcomes.

What Medicare’s New TEAM Hospital Payment Model Will Mean For Seniors

TEAM may encourage hospitals to improve the quality of the care their patients receive after being discharged. But it also risks further burdening family caregivers. I

These Lesser Known AI Stocks Are Reaching Record Highs

After a decade of modest gains, data storage companies like Sandisk, Seagate and Western Digital had a stunning run in 2025.

Buying Longevity: The New Run Rate Of Living And Living In Retirement

From CES to retail shelves, technology to extend longevity and healthspan is becoming a new run-rate cost of living and living in retirement.

AI Drug Discovery Unicorn Insilico Medicine Jumps In Hong Kong Trading Debut

After raising $293 million in the IPO, Insilico Medicine aims to become “a massive source of innovative drugs for pharma companies,” says founder Alex Zhavoronkov.